Pharmaceutical Development
Bringing new medicines to market
The Novartis Pharmaceutical Development organization is responsible for developing drug candidates from the Novartis Institutes for BioMedical Research, Novartis Biologics or licensing partners. There are 149 projects in the pharmaceutical product pipeline.
Novartis aspires to transform drug development by applying innovative approaches to enhance quality and productivity of clinical development and significantly decrease development time.
A worldwide commitment
Novartis Pharmaceutical Development employs more than 7 000 associates in several locations globally:
-
Basel, Switzerland
-
East Hanover, New Jersey, US
-
Cambridge, Massachusetts, US
-
Horsham, United Kindom
-
Shanghai, China
-
Changshu, China
-
Tokyo, Japan
-
Hyderabad, India
Discover our Development locations
Drug discovery and development process
Our products
We are a leader in offering medicines to protect health, cure disease and improve well-being.
Patient groups
Our commitment to high-quality healthcare has led to partnerships between Novartis and patient groups.